1. Treatment with Anlotinib After Chemotherapy and EGFR-TKI Resistance in Lung Adenosquamous Carcinoma with Concurrent EGFR and PIK3CA Mutations: A Case Report and Literature Review
   Yonghui Wu et al, 2021, Cancer Management and Research CrossRef
2. The Novelty of miRNAs as a Clinical Biomarker for the Management of PCOS
   Rana Alhamdan et al, 2022, Polycystic Ovary Syndrome - Functional Investigation and Clinical Application CrossRef
3. Inhibition of SGK1 potentiates the anticancer activity of PI3K inhibitor in NSCLC cells through modulation of mTORC1, p‑ERK and β‑catenin signaling
   Ramesh Kale et al, 2023, Biomedical Reports CrossRef